HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ia-like antigen expression on biologically different human melanoma cell lines.

Abstract
Ia-like antigen binding of a large panel of monoclonal antibodies (six anti-human Ia-like monoclonal antibodies and ten murine anti-Ia monoclonal antibodies cross-reactive with human Ia-like antigens) were compared on seven permanent human melanoma cell lines by radioimmunoassay. Cell lines were initiated from primary or metastatic tumors and presented various levels of tumorigenicity (assessed by heterotransplantation in nude mice) and pigmentation (shown by 5-S-cysteinyldopa determination and cytological data). Two cell lines originated from the same primary melanoma, while two other pairs of cell lines originated from superficial spreading melanoma or metastatic lymph node of the same patients. Identical Ia-like allodeterminants were found in cell lines of the same individual origin. Quantitative expression of beta 2-microglobulin and Ia-like antigens was similar in all cell lines except for one, in which these molecules were expressed in lower amounts. These results indicate that Ia-like antigen expression of the cell lines is unrelated to primary or metastatic origin, degree of pigmentation and ability to grow in nude mice.
AuthorsM Reynier, S Lebec, C Rohner, J Kalil, C Aubert
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 20 Issue 5 Pg. 659-65 (May 1984) ISSN: 0277-5379 [Print] England
PMID6376131 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • HLA-D Antigens
  • Histocompatibility Antigens Class II
  • beta 2-Microglobulin
Topics
  • Adult
  • Antibodies, Monoclonal (immunology)
  • Cell Line
  • Cross Reactions
  • Female
  • HLA-D Antigens
  • Histocompatibility Antigens Class II (analysis)
  • Humans
  • Male
  • Melanoma (immunology)
  • Middle Aged
  • Radioimmunoassay
  • beta 2-Microglobulin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: